pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·1h ago·1 min read
save

Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trial

Plus news about AC Immune, Lilly's Adverum and SiranBio. 🤝 Eli Lilly signs vaccine deal with Amplitude: The companies will work to develop vaccines using “trans-amplifying RNA,” or taRNA, for infectious ...

Aug 20, 2026·read at Endpoints ↗

August 20, 2026 10:33 AM EDT News Briefing Lil­ly part­ners with Am­pli­tude on vac­cines; Ot­su­ka scraps psy­che­del­ic tri­al ENDPOINTS Plus news about AC Im­mune, Lil­ly’s Ad­verum and Sir­an­Bio. 🤝 Eli Lil­ly signs vac­cine deal with Am­pli­tude: The com­pa­nies will work to Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
75 words · retrieved 53m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 37m agoUsing gray-market versions of Lilly’s triple-G leads to relatively poor weight loss, study findsEndpoints
  • 1h agoTry first, evaluate later: How the FDA is approaching digital health devicesEndpoints
  • 2h agoWuXi Bio to offload chromatography unit; Cabaletta names another CDMO partnerEndpoints
  • 2h agoEpic's AI push overlaps with health tech startupsEndpoints
  • 4h agoFDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorderEndpoints